Cutibacterium acnes bacterial proteins and cell wall components

Cutibacterium acnes (formerly Propionibacterium acnes) is a Gram-positive anaerobic bacterium that resides within the human pilosebaceous unit and is a primary driver of acne vulgaris (Source: StatPearls, 2023). The target encompasses a variety of structural and secreted components, including peptidoglycan and lipoteichoic acid, which serve as pathogen-associated molecular patterns (PAMPs) that activate Toll-like receptor 2 (TLR2) on host immune cells (Source: J Invest Dermatol, 2013). Additionally, C. acnes secretes virulence factors such as lipases, which degrade sebum into pro-inflammatory free fatty acids, and Christie-Atkins-Munch-Petersen (CAMP) factors that act as pore-forming toxins (Source: Microbiology, 2016). Pharmacological intervention typically involves antibiotics that disrupt bacterial protein synthesis or oxidizing agents like benzoyl peroxide that non-specifically damage bacterial components (Source: PubChem). Emerging therapeutic strategies include the development of vaccines and monoclonal antibodies specifically targeting CAMP factors to neutralize inflammation while preserving the broader skin microbiome (Source: J Invest Dermatol, 2019).

Other names

Propionibacterium acnes componentsC. acnes antigensSkin microbiota virulence factorsBacterial cell wall components of skin bacteria

Inhibition of bacterial protein synthesis via binding to the 50S or 30S ribosomal subunits, oxidative destruction of bacterial proteins and membranes, or competitive inhibition of bacterial enzymes involved in metabolism.